42nd week of 2019 patent applcation highlights part 23 |
Patent application number | Title | Published |
20190315770 | COMPOSITION FOR HARDENING SOFT TISSUE | 2019-10-17 |
20190315771 | NOVEL 2-ACYLAMINOTHIAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF | 2019-10-17 |
20190315772 | GLUCOSE UPTAKE INHIBITORS | 2019-10-17 |
20190315773 | COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY | 2019-10-17 |
20190315774 | TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS | 2019-10-17 |
20190315775 | MODIFIED PHENYLPHTHALIMIDE AND PHARMACEUTICAL COMPOSITION HAVING SAME AS ACTIVE INGREDIENT | 2019-10-17 |
20190315776 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | 2019-10-17 |
20190315777 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END | 2019-10-17 |
20190315778 | Low-viscosity crosslinkers containing alkoxysilane groups | 2019-10-17 |
20190315779 | GLYCOLURIL RING-CONTAINING ORGANOSILICON COMPOUND AND MAKING METHOD | 2019-10-17 |
20190315780 | ALKYL ETHER SUBSTITUTED CYCLOTRISILOXANES AND PREPARATION METHOD THEREOF | 2019-10-17 |
20190315781 | MONOALKYL TIN COMPOUNDS WITH LOW POLYALKYL CONTAMINATION, THEIR COMPOSITIONS AND METHODS | 2019-10-17 |
20190315782 | MONOALKYL TIN COMPOUNDS WITH LOW POLYALKYL CONTAMINATION, THEIR COMPOSITIONS AND METHODS | 2019-10-17 |
20190315783 | PRODRUGS OF GLUTAMINE ANALOGS | 2019-10-17 |
20190315784 | PRODRUGS OF GLUTAMINE ANALOGS | 2019-10-17 |
20190315785 | PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS | 2019-10-17 |
20190315786 | PHOSPHAZENE COMPOUND, PREPARATION METHOD AND USE THEREOF | 2019-10-17 |
20190315787 | METAL COMPLEXES | 2019-10-17 |
20190315788 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2019-10-17 |
20190315789 | PROLIFERATIVE DISEASE TREATMENT METHODS WITH PHOSPHAPLATIN COMPLEXES | 2019-10-17 |
20190315790 | SYNTHESIS OF D-ALLULOSE | 2019-10-17 |
20190315791 | METHOD FOR PURIFYING ALLULOSE CONVERSION REACTION PRODUCT | 2019-10-17 |
20190315792 | MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES | 2019-10-17 |
20190315793 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | 2019-10-17 |
20190315794 | Compositions and Methods for Reverse Automated Nucleic Acid Synthesis | 2019-10-17 |
20190315795 | CRYSTALLINE 3',5'-CYCLIC DIGUANYLIC ACID | 2019-10-17 |
20190315796 | ANTISENSE NUCLEIC ACIDS | 2019-10-17 |
20190315797 | ABIRATERONE DERIVATIVE AND FORMULATIONS THEREOF | 2019-10-17 |
20190315798 | WITHANOLIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-10-17 |
20190315799 | SCALABLE PRODUCTION OF GENETICALLY ENGINEERED NANOFIBROUS MACROSCOPIC MATERIALS VIA FILTRATION | 2019-10-17 |
20190315800 | A METHOD OF ENHANCING THE PERFORMANCE OF CHROMATOGRAPHY METHODS FOR PURIFICATION OF PROTEINS | 2019-10-17 |
20190315801 | GENE ENCODING ALANYL- GLUTAMINE DIPEPTIDE BIOSYNTHETIC ENZYME AND APPLICATION THEREOF | 2019-10-17 |
20190315802 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2019-10-17 |
20190315803 | IMPROVED ANGIOGENESIS-INHIBITING PEPTIDE AND COMPOSITION FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT | 2019-10-17 |
20190315804 | PEPTIDES CAPABLE OF REACTIVATING p53 MUTANTS | 2019-10-17 |
20190315805 | TARGETED NONINVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS | 2019-10-17 |
20190315806 | POLYMYXIN DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | 2019-10-17 |
20190315807 | VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCING THE EXPRESSION OF ANTIBODIES | 2019-10-17 |
20190315808 | Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity | 2019-10-17 |
20190315809 | CYTOPLASMIC TRANSDUCTION PEPTIDE AND INTRACELLULAR MESSENGER COMPRISING SAME | 2019-10-17 |
20190315810 | FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION | 2019-10-17 |
20190315811 | NOVEL PROTEIN AGAINST FUNGAL PATHOGENS | 2019-10-17 |
20190315812 | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES | 2019-10-17 |
20190315813 | PLASMID-BASED CTX PHAGE REPLICATION SYSTEM AND VIBRIO CHOLERAE STRAIN THAT CAN BE INFECTED BY CTX PHAGE AND CAN BE USED FOR CHOLERA TOXIN PRODUCTION | 2019-10-17 |
20190315814 | LANTIBIOTIC VARIANTS AND USES THEREOF | 2019-10-17 |
20190315815 | POLYPEPTIDE AND YEAST CELL COMPOSITIONS AND METHODS OF USING THE SAME | 2019-10-17 |
20190315816 | PROTRANSDUCINE-C: GENE TRANSFER ACTIVATOR | 2019-10-17 |
20190315817 | MULTIMERIC AND MULTIVALENT POLYMER COMPRISING MULTIMERIZATION PEPTIDE DOMAIN | 2019-10-17 |
20190315818 | RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF | 2019-10-17 |
20190315819 | PEPTIDE DIRECTED PROTEIN KNOCKDOWN | 2019-10-17 |
20190315820 | A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same | 2019-10-17 |
20190315821 | COMPOSITIONS COMPRISING HEPCIDIN AND METHODS OF USE THEREOF | 2019-10-17 |
20190315822 | Growth Differentiation Factor 15 (GDF-15) Polypeptides | 2019-10-17 |
20190315823 | SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES | 2019-10-17 |
20190315824 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | 2019-10-17 |
20190315825 | RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY | 2019-10-17 |
20190315826 | Method for Increasing the Secretion Levels of Interleukin 2 and Proteins Derived from it | 2019-10-17 |
20190315827 | COMPOSITIONS AND METHODS FOR TREATMENT OF TYPE 1 DIABETES | 2019-10-17 |
20190315828 | INSULIN-FC FUSIONS AND METHODS OF USE | 2019-10-17 |
20190315829 | COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS | 2019-10-17 |
20190315830 | COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS | 2019-10-17 |
20190315831 | COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS | 2019-10-17 |
20190315832 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS | 2019-10-17 |
20190315833 | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers | 2019-10-17 |
20190315834 | SIRP alpha-CD70 FUSION PROTEIN AND METHODS OF USE THEREOF | 2019-10-17 |
20190315835 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | 2019-10-17 |
20190315836 | ALBUMIN VARIANTS | 2019-10-17 |
20190315837 | P97 FUSION PROTEINS | 2019-10-17 |
20190315838 | ANTIBODIES THAT BIND ZIKA VIRUS ENVELOPE PROTEIN AND USES THEREOF | 2019-10-17 |
20190315839 | DENGUE VIRUS-LIKE PARTICLE, ANTIBODY AGAINST DENGUE VIRUS, AND COMPOSITION COMPRISING THE SAME | 2019-10-17 |
20190315840 | ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE | 2019-10-17 |
20190315841 | Antibody-Based Molecules Specific for the Truncated ASP421 Epitope of Tau and Their Uses in the Diagnosis and Treatment of Tauopathy | 2019-10-17 |
20190315842 | INHIBITORS OF COMPLEMENT FACTOR H | 2019-10-17 |
20190315843 | ANTIBODIES RECOGNIZING ALPHA-SYNUCLEIN | 2019-10-17 |
20190315844 | ANTI-GP73 MONOCLONAL ANTIBODIES AND METHODS OF OBTAINING THE SAME | 2019-10-17 |
20190315845 | HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF | 2019-10-17 |
20190315846 | Antibodies to Human Alpha-Synuclein | 2019-10-17 |
20190315847 | THERAPEUTIC COMBINATIONS USING IGF1R PATHWAY INHIBITORS, AND METHODS TO PREDICT ANTI-IGF1R THERAPEUTIC EFFICACY | 2019-10-17 |
20190315848 | ANTI-SECRETOGRANIN III (SCG3) ANTIBODIES AND USES THEREOF | 2019-10-17 |
20190315849 | METHOD OF TREATING OR PREVENTING STROKE | 2019-10-17 |
20190315850 | Antibodies Specific for TGF-Beta | 2019-10-17 |
20190315851 | ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF | 2019-10-17 |
20190315852 | COMBINED TREATMENT WITH NETRIN-1 INTERFERING DRUG AND IMMUNE CHECKPOINT INHIBITORS DRUGS | 2019-10-17 |
20190315853 | ANTIBODIES TO IL-15 | 2019-10-17 |
20190315854 | ANTIBODIES, COMPOSITION AND KITS COMPRISING SAME, AND METHODS OF USE THEREOF | 2019-10-17 |
20190315855 | Therapeutic DLL4 Binding Proteins | 2019-10-17 |
20190315856 | Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor | 2019-10-17 |
20190315857 | TREATMENT OF PERIPHERAL T CELL LYMPHOMA | 2019-10-17 |
20190315858 | ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF | 2019-10-17 |
20190315859 | ANTIBODY AGENTS SPECIFIC FOR HUMAN CD19 AND USES THEREOF | 2019-10-17 |
20190315860 | HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE | 2019-10-17 |
20190315861 | METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS | 2019-10-17 |
20190315862 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF METASTASES | 2019-10-17 |
20190315863 | TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF | 2019-10-17 |
20190315864 | SINGLE DOMAIN ANTIBODY AND DERIVATIVE PROTEINS THEREOF AGAINST CTLA4 | 2019-10-17 |
20190315865 | METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY | 2019-10-17 |
20190315866 | Antibodies Directed Against ICOS and Uses Thereof | 2019-10-17 |
20190315867 | ANTI-TIGIT ANTIBODIES | 2019-10-17 |
20190315868 | Therapeutic and diagnostic methods for cancer | 2019-10-17 |
20190315869 | METHODS FOR TREATING CANCER IN PATIENTS WITH ELEVATED LEVELS OF BIM | 2019-10-17 |